Biomedica-Anpartsselskab: Financial statements 2021
CVR: 15234474
Biomedica-Anpartsselskab (CVR 15234474) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 512,204 and a net result of DKK 402,016 compared with DKK 827,644 the year before. That is a decrease of 51.9% compared with the year before. Equity amounted to DKK 1,336,566. The solvency ratio was 75.9%.
- Gross Profit
- 512,204 kr.
- Profit/Loss
- 402,016 kr.
- Equity
- 1,336,566 kr.
- Total Assets
- 1,761,822 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 512 t. | 402 t. | 1.3 mio. | - |
| 2020 | 2 mio. | 1.1 mio. | 828 t. | 916 t. | - |
| 2019 | 2.7 mio. | 1.7 mio. | 1.4 mio. | 107 t. | - |
| 2018 | 600 t. | 38 t. | 38 t. | -1.3 mio. | - |
| 2017 | 0 | -4 t. | -4 t. | -1.3 mio. | - |
Find more companies like Biomedica-Anpartsselskab
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
Biomedica-Anpartsselskab has published its annual report for 2020. Revenue came to DKK 1,975,000, and the net result was DKK 827,644.
About Biomedica-Anpartsselskab
Biomedica-Anpartsselskab is a Danish company of the type Anpartsselskab based in Frederiksberg C, founded in 1991. The company is registered under the industry Vikarbureauers aktiviteter og anden personaleformidling. The management consists of Lars Anders Baumbach. The company is owned by Lars Anders Baumbach. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK -28,050 compared with DKK 307,277 the year before. Equity amounted to DKK 2,702,360.
